Premium Nahrungsergänzungsmittel | artgerecht

Glucose Tolerance Markers – Definition and Relevance

Glucose tolerance markers are laboratory values that indicate how well the body processes sugar. They are essential for the early detection of diabetes and prediabetes.

Regular tips about health Regular tips about health

Things worth knowing about "Glucose Tolerance Markers"

Glucose tolerance markers are laboratory values that indicate how well the body processes sugar. They are essential for the early detection of diabetes and prediabetes.

What Are Glucose Tolerance Markers?

Glucose tolerance markers are laboratory parameters that measure how efficiently the body absorbs, utilizes, and regulates glucose (blood sugar). They reflect the metabolic ability to return blood glucose levels to a normal range after a meal or a standardized sugar load. Impaired glucose tolerance can be an early indicator of type 2 diabetes, prediabetes, or metabolic syndrome.

Key Glucose Tolerance Markers

Fasting Plasma Glucose (FPG)

The fasting plasma glucose is measured after at least 8 hours of fasting. A value below 100 mg/dL (5.6 mmol/L) is considered normal. Values between 100 and 125 mg/dL indicate impaired fasting glucose (IFG), while values of 126 mg/dL or higher on two separate occasions confirm a diagnosis of diabetes.

Oral Glucose Tolerance Test (OGTT)

In the oral glucose tolerance test, the patient drinks a standardized glucose solution (typically 75 g). Blood glucose is measured while fasting and at 1 and 2 hours after ingestion. A 2-hour value between 140 and 199 mg/dL indicates impaired glucose tolerance (IGT); a value of 200 mg/dL or higher confirms diabetes.

HbA1c (Glycated Haemoglobin)

The HbA1c value reflects the average blood glucose level over the past 2 to 3 months. It is formed when glucose binds chemically to haemoglobin in red blood cells. An HbA1c below 5.7% is considered normal; values between 5.7% and 6.4% indicate prediabetes; 6.5% or higher confirms diabetes.

Insulin and C-Peptide

Insulin and C-peptide are markers of pancreatic insulin secretion. Elevated fasting insulin levels may point to insulin resistance, a condition in which the body needs to produce more insulin to maintain normal blood glucose. C-peptide is co-secreted with insulin and provides a measure of endogenous insulin production.

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance)

The HOMA-IR index is calculated from fasting insulin and fasting glucose values and is a widely used measure of insulin resistance. An elevated HOMA-IR (above 2.0 to 2.5, depending on the laboratory) suggests reduced insulin sensitivity.

Causes of Impaired Glucose Tolerance

Overweight and obesity, especially visceral (abdominal) fat accumulation
Physical inactivity and sedentary lifestyle
An unbalanced diet high in refined carbohydrates and added sugars
Genetic predisposition and family history of diabetes
Hormonal disorders (e.g., polycystic ovary syndrome, Cushing syndrome)
Certain medications (e.g., corticosteroids, antipsychotics)
Chronic stress and insufficient sleep

Diagnosis and Clinical Relevance

Glucose tolerance markers are used in routine health screenings, for high-risk individuals, and for diagnostic workups in symptomatic patients. Combining multiple markers provides a more comprehensive assessment of diabetes risk. Early detection of impaired glucose tolerance is especially valuable, as lifestyle interventions at this stage can often prevent progression to full-blown diabetes.

Treatment and Prevention of Impaired Glucose Tolerance

Dietary changes: Reducing intake of sugary and highly processed foods while increasing fibre, vegetables, and whole grains
Regular physical activity: At least 150 minutes of moderate exercise per week has been shown to improve insulin sensitivity
Weight reduction: Losing as little as 5 to 10% of body weight can significantly improve glucose tolerance
Pharmacological therapy: Metformin or other antidiabetic agents may be considered in cases of advanced insulin resistance or prediabetes
Regular monitoring: Annual review of glucose tolerance markers is recommended for individuals at risk

References

World Health Organization (WHO) - Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia (2006). Available at: https://www.who.int
American Diabetes Association - Standards of Medical Care in Diabetes 2024. Diabetes Care, 47(Suppl 1), S1-S321.
Tabak A.G., Herder C., Rathmann W., Brunner E.J., Kivimaki M. - Prediabetes: a high-risk state for diabetes development. The Lancet, 2012; 379(9833): 2279-2290.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category